Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin E for Alzheimer's disease.

N Tabet1, J Birks, Grimley Evans J

  • 1Old Age Psychiatry, The Maudsley Hospital, Denmark Hill, London, UK, SE5 8AZ. N.Tabet@iop.kcl.ac.uk

The Cochrane Database of Systematic Reviews
|October 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Practical Efficiency Limit of Methylammonium Lead Iodide Perovskite (CH<sub>3</sub>NH<sub>3</sub>PbI<sub>3</sub>) Solar Cells.

The journal of physical chemistry letters·2018
Same author

APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures.

NeuroImage·2012
Same author

Pro-inflammatory cytokines IL-1β and TNF-α are not associated with blood homocysteine concentration in Alzheimer's disease.

Current Alzheimer research·2012
Same author

Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease.

Journal of medical genetics·2011
Same author

Ultra-fast Microwave Synthesis of ZnO Nanowires and their Dynamic Response Toward Hydrogen Gas.

Nanoscale research letters·2010
Same author

Knowledge and practices of dementia patients across Sussex in relation to vitamin and herbal extract use.

International journal of geriatric psychiatry·2010

Vitamin E may offer some benefit for Alzheimer's disease patients, potentially delaying disease progression. However, more research is needed due to limited evidence and an observed increase in falls among users.

Area of Science:

  • Neuroscience
  • Gerontology
  • Pharmacology

Background:

  • Vitamin E, a potent antioxidant, is investigated for Alzheimer's disease (AD) due to free radical involvement in AD pathology.
  • Antioxidant properties of Vitamin E may mitigate oxidative stress implicated in neurodegenerative processes of AD.

Purpose of the Study:

  • To evaluate the therapeutic effects of Vitamin E supplementation in individuals diagnosed with Alzheimer's disease.
  • To synthesize evidence from randomized controlled trials on Vitamin E for Alzheimer's disease management.

Main Methods:

  • Systematic search of the Cochrane Dementia Group Register of Clinical Trials for relevant randomized controlled trials (RCTs) up to July 2000.
  • Inclusion criteria focused on double-blind, placebo-controlled trials of Vitamin E in Alzheimer's disease patients.

Related Experiment Videos

  • Data extraction and analysis were performed by independent reviewers, assessing study quality and patient outcomes.

    • Main Results:

    • One RCT (Sano 1997) met the inclusion criteria, involving 341 participants with moderate Alzheimer's disease.
    • Vitamin E showed a potential benefit in delaying a composite endpoint (death, institutionalization, loss of activities of daily living, or severe dementia) with an odds ratio of 0.49 (95% CI 0.25 to 0.96).
    • A significant increase in falls was observed in the Vitamin E group (OR 3.07, 95% CI 1.09 to 8.62) compared to placebo.

    Conclusions:

    • Current evidence on Vitamin E efficacy for Alzheimer's disease is insufficient, with the single trial yielding interpretable results only for moderate AD.
    • The potential benefit of Vitamin E warrants further investigation, but the increased risk of falls requires careful consideration and evaluation.
    • Further high-quality research is necessary to definitively establish Vitamin E's role in Alzheimer's disease treatment.